Home » Topics » Regulatory

Regulatory
RSS

FDA approves Yupelri for maintenance treatment of COPD

Nov. 12, 2018

European Commission approves expanded label for Trelegy Ellipta in COPD

Nov. 9, 2018

FDA approves Bijuva for moderate to severe hot flashes due to menopause

Oct. 30, 2018

France becomes first country to market baclofen preparation to reduce alcohol consumption

Oct. 29, 2018

FDA approves Dupixent as add-on maintenance therapy for asthma

Oct. 22, 2018

FDA approves Talzenna for germline BRCA-mutated HER2-negative breast cancer

Oct. 17, 2018

FDA approves Yutiq for chronic noninfectious posterior segment uveitis

Oct. 15, 2018

Revcovi approved in U.S. for ADA-SCID

Oct. 8, 2018

FDA approves Nuzyra for CABP and ABSSSI

Oct. 3, 2018

FDA approves Seysara for acne

Oct. 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.